Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cells Tissues Organs ; 191(6): 443-52, 2010.
Article in English | MEDLINE | ID: mdl-20130390

ABSTRACT

Since the discovery that bone morphogenetic proteins (BMPs) are able to induce ectopic bone formation, considerable effort has been devoted to apply it for bone regeneration. BMP activity needs to be temporally and spatially controlled and the organism has devised ways to achieve it. Here we show that the BMP inhibitor chordin-like 1 can interfere with BMP2 signalling thereby affecting the osteogenic differentiation of MC3T3-E1 cells. Besides its function as a BMP antagonist, chordin-like 1 enhanced the proliferation of human mesenchymal stem cells (hMSCs) in a BMP2-independent manner. When MC3T3-E1 cells were exposed to recombinant chordin-like 1 there was an inhibition of alkaline phosphatase (ALP) expression, whereas in the case of hMSCs no effect was observed. However, chordin-like 1 dose-dependently increased the proliferation of hMSCs. This effect is probably BMP2 independent because the chordin-like 1 concentration that stimulates proliferation does not interfere with BMP signalling monitored by a Smad-dependent reporter gene. Our data point towards a novel, BMP-independent role of chordin-like 1 in hMSC proliferation.


Subject(s)
Eye Proteins/metabolism , Eye Proteins/pharmacology , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/metabolism , Nerve Tissue Proteins/metabolism , Nerve Tissue Proteins/pharmacology , Alkaline Phosphatase/metabolism , Animals , Bone Morphogenetic Protein 2/genetics , Bone Morphogenetic Protein 2/metabolism , Bone Morphogenetic Protein 2/pharmacology , Cell Line , Cell Proliferation/drug effects , Cells, Cultured , Eye Proteins/genetics , Flow Cytometry , Humans , Mesenchymal Stem Cells/cytology , Mice , Nerve Tissue Proteins/genetics , Oligonucleotide Array Sequence Analysis , Osteogenesis/drug effects , Osteogenesis/genetics
2.
Tissue Eng Part A ; 15(12): 3857-67, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19694522

ABSTRACT

Collagen is the main protein component of the extracellular matrix of bone, and it has structural and instructive properties. Collagen undergoes many post-translational modifications, including extensive crosslinking. Although defective crosslinking has been implicated in human syndromes (e.g., osteogenesis imperfecta or Ehlers-Danlos syndrome), it is not clear to what extent crosslinking is necessary for collagen's instructive properties during bone formation. Here we report that inhibition of collagen crosslinking in the mouse pre-osteoblast cell line MC3T3-E1 impairs the osteogenic program. Genome-wide expression profiling of beta-aminopropionitrile-treated and control cells revealed that matrix deposition by MC3T3-E1 cells provides a feed back signal, driving cells through the differentiation process, that is strongly impaired when crosslinking is inhibited. Inhibition of crosslinking did not affect osteogenic differentiation of human mesenchymal stem cells (hMSCs), shown by the expression of alkaline phosphatase and genome-wide gene expression analysis, although it enhances matrix mineralization. In conclusion, collagen crosslinking harbors instructive properties in MC3T3-E1 differentiation but plays a more-passive role in differentiation of bone marrow-derived hMSCs.


Subject(s)
Cell Differentiation , Collagen/metabolism , Cross-Linking Reagents/metabolism , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Osteoblasts/cytology , Osteoblasts/metabolism , Animals , Cell Differentiation/drug effects , Enzyme Inhibitors/pharmacology , Extracellular Matrix/drug effects , Extracellular Matrix/genetics , Gene Expression Profiling , Gene Expression Regulation/drug effects , Humans , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/enzymology , Mice , Models, Biological , Osteoblasts/drug effects , Osteoblasts/enzymology , Osteogenesis/drug effects , Protein-Lysine 6-Oxidase/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...